Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AWARE: A World-wide Antihistamine-Refractory Chronic Urticaria Patient Evaluation

NCT02435238 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

NCT NCT02435238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02435238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AWARE: A World-wide Antihistamine-Refractory Chronic Urticaria Patient Evaluation
Lead sponsor
Novartis Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
September 3, 2014
Completion date
September 27, 2017
Enrollment
180 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

chronic urticaria